MedPath

Evaluation of therapeutic effect of Bushen Zhiwang decoction on bone destruction in patients with Rheumatoid Arthritis and cohort study of bone destruction markers

Phase 1
Recruiting
Conditions
Rheumatoid Arthritis
Registration Number
ITMCTR2100004230
Lead Sponsor
Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients aged 16-70 years;
2. Patients who meet the diagnostic criteria of RA and the diagnostic criteria of traditional Chinese medicine for liver and kidney deficiency syndrome;
3. Patients with anteroposterior radiographs of both hands (including wrist) before and after treatment for one year;
4. Patients with wrist X-ray grade I-III;
5. Patients with informed consent.

Exclusion Criteria

1. Mental patients;
2. Patients with severe malnutrition or severe damage of heart, brain, kidney and hematopoietic system;
3. Patients with other rheumatic diseases;
4. Patients with joint dysfunction;
5. Patients with incomplete information.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sharp Scoring;
Secondary Outcome Measures
NameTimeMethod
Rankl;
© Copyright 2025. All Rights Reserved by MedPath